INSIGHTS ON PHARMACEUTICAL PACKAGING

• Sachet Packaging Solutions

  Discover versatile, high-quality sachets for manufacturers and consumers with an ideal fill weight of 2 grams and above that is suitable for food or liquid formulas.

• Determining The Limit Of Detection In CCIT

  Accurately determining the smallest detectable defect in pharmaceutical packaging is essential for sterility. Learn how test sensitivity, positive controls, and regulatory standards shape CCI strategies.

• Integrated Solutions Mitigating Challenges PosedBy RNA-Based Drugs

  Safeguard RNA drug stability with an integrated manufacturing strategy. Combining specialized analytics, advanced packaging, and precision assembly ensures molecular integrity and efficient production.

• Achieving EU GMP Annex 1 Compliance For Contamination Control

  Gain insight into three areas that have been key in ensuring a robust contamination control strategy to help ensure compliance with the updated Annex 1 regulation: planning, people, and products.

• Material Transfer Into A Cleanroom: How To Reduce Contamination Risk At Every Step

  4/20/2026

  Evaluate packaging integrity and master wiping techniques to prevent cleanroom contamination. Focus on surface coverage and controlled transfer paths to ensure consistent product safety and quality.

• Ensuring Integrity: A Comprehensive Approach To CCI

  1/8/2026

  Deterministic CCI testing ensures compliance in packaging. Learn how advanced methods like Vacuum Decay, HVLD, and Helium Leak Detection deliver results aligned with USP 1207 and global standards.

• New Standards For Elastomeric Components In Sterile Packaging

  1/20/2026

  USP’s new elastomeric packaging standards shift testing to full system‑level evaluation, strengthen integrity and usability expectations, and place compliance responsibility on drug developers.

• Rare Diseases And The Integrated CDMO Support System

  4/7/2026

  Champion the rare‑disease community by advancing development models built on precision, continuity and global coordination that ensure every dose reaches the patients who need it most.

• Enabling Complex Phase IIa Dosing Through Flexible Clinical Packaging Design

  5/6/2026

  Discover how flexible, patient‑centric clinical packaging supports complex Phase IIa dosing while protecting timelines, ensuring compliance, and avoiding costly primary packaging changes.